Identification of quantitative trait loci for haloperidol-induced catalepsy on mouse chromosome

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 3, 1999, Pages 1337-1346

  Rasmussen, Erik ^a   Cipp, Laura ^a   Hitzemann, Robert ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; SEROTONIN 2A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALEPSY; CHROMOSOME 1; CHROMOSOME 14; CHROMOSOME 9; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; GENE LOCUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PIEBALDISM; PRIORITY JOURNAL; QUANTITATIVE TRAIT; RECEPTOR BINDING; SEX DIFFERENCE; STRAIN DIFFERENCE;

ANIMALS; ANTIPSYCHOTIC AGENTS; CATALEPSY; CHROMOSOME MAPPING; FEMALE; GENOME; GENOTYPE; HALOPERIDOL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHENOTYPE; QUANTITATIVE TRAIT, HERITABLE;

EID: 0032774210     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Basten CJ, Weir BS and Zeng Z-B (1997) QTL Cartographer: A Reference Manual and Tutorial for QTL Mapping. Department of Statistics, North Carolina State University, Raleigh, NC.
2. Boehme RE and Ciaranello RD (1983) Genetic control of dopamine and serotonin receptors in brain regions of inbred mice. Brain Res 266:51-65.
3. Calne DB (1978) Parkinsonism: Clinical and neuropharmacological aspects. Postgrad Med 64:82-88.
4. 125I]-epidepride: A dopamine D-2 receptor antagonist ligand. J Label Cmpds Radiopharm 29:745-752.
5. Dains K, Hitzemann B and Hitzemann R (1996) Genetics, neuroleptic response and the organization of the cholinergic neurons in the mouse striatum. J Pharmacol Exp Ther 279:1430-1438.
6. Davarsi A (1998) Experimental strategies for the genetic dissection of complex traits in animal models. Nat Genet 18:19-24.
7. Darvasi A, Weinreb A, Minke V, Weller JI and Soller M (1993) Detecting marker-QTL linkage and estimating QTL gene effect and map location using a saturated genetic map. Genetics 134:943-951.
8. Dietrich WF, Miller J, Steen R, Merchant MA, Damron-Boles D, Husain Z, Dredge R, Daly MJ, Ingalls KA and O'Connor TJ (1996) A comprehensive genetic map of the mouse genome. Nature (Lond) 380:149-152.
9. Dixon WJ (1965) The up-and-down method for small samples. Am Stat Assoc J 967-978.
10. Doshay LJ and Constable K (1957) Treatment of paralysis agitans with or-phenadrine (Dispal) hydrochloride: Results in one hundred and seventy-six cases. J Am Med Assoc 163:1352-1357.
11. 2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet 97:614-619.
12. Flint J, Corley R, DeFries JC, Fulker DW, Gray JA, Miller S and Collins AC (1995) A simple genetic basis for a complex psychological trait in laboratory mice. Science (Wash DC) 269:1432-1435.
13. Hitzemann RJ, Dains K, Bur-Langing CM and Zahniser NR (1991) Selection of the haloperidol responsive and hatoperidol non-responsive lines of mice. Psychopharmacology 103:244-250.
14. Hitzemann B, Dains K, Kanes S and Hitzemann R (1994) Further studies on the relationship between dopamine cell density and haloperidol-induced catalepsy. J Pharmacol Exp Ther 271:969-976.
15. Hitzemann RJ, Hitzemann B, Dains K, Qian Y and Kanes S (1993) Dopamine and acetylcholine cell density in the neuroleptic responsive (NR) and neuroleptic non-responsive (NNR) lines of mice. J Pharmacol Exp Ther 266:431-438.
16. Hitzemann R, Hitzemann B, Kanes S and Dains K (1995) Genetics and organization of the basal ganglia. Int Rev Neurobiol 38:43-94.
17. Kanes S, Dains K, Cipp L, Gatley J, Hitzemann B, Rasmussen E, Sanderson S, Silverman M and Hitzemann R (1996) Mapping the genes for haloperidol-induced catalepsy. J Pharmacol Exp Ther 877:1016-1025.
18. Kanes S, Hitzemann B and Hitzemann R (1993) On the relationships between dopamine receptor density and haloperidol-induced catalepsy among eight inbred mouse strains. J Pharmacol Exp Ther 267:538-545.
19. Kline L, Decena E, Hitzemann R and McCaughran J Jr (1998) Acoustic startle, prepulse inhibition, locomotion, and latent inhibition in the neuroleptic-responsive (NR) and neuroleptic-nonresponsive (NNR) lines of mice. Psychopharmacology 139:322-331.
20. Lander ES and Botstein E (1989) Mapping mendelian factors underlying uantitative traits using RFLP linkage maps. Genetics 121:185-199.
21. Lander ES and Krugylak L (1995) Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247.
22. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA 89:8155-8159.
23. 2 receptors and uptake sites in the neocortex of the rhesus monkey. J Comp Neurol 280:27-42.
24. 2A/C antagonist, reverse haloperidol-induced catalepsy on rats independently of striatal dopamine release. Psychopharmacology 131:57-63.
25. i values. J Pharmacol Exp Ther 251:238-246.
26. McCaughran J, Bell J and Hitzemann R (1999) On the relationship of high frequency hearing loss and cochlear pathology to the acoustic startle response (ASR) and prepulse inhibition of the ASR in the BXD recombinant inbred series. Behav Gen, in press.
27. McCaughran JA Jr, Mahjubi E, Decena E and Hitzemann R (1997) Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition. Psychopharmacology 134:131-140.
28. Patel N, Hitzemann B and Hitzemann R (1997) Genetics, haloperidol, and the Fos response in the basal ganglia: A comparison of the C57BL/6J and DBA/2J inbred mouse strains. Neuropsychopharmacology 18:480-491.
29. Patel NV, Cipp L, Mahjubi E, McCaughran J and Hitzemann R (1998) Quantitativetrait loci mapping for haloperidol-induced catalepsy in the C57BL/6J X DBA/2J F2 population (Abstract). J Soc Neurosci 23:660.
30. Pazos A, Cortés R and Palacios M (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 348:231-249.
31. Qian Y, Hitzemann B and Hitzemann R (1992) D1 and D2 dopamine receptor distribution in the neuroleptic nonresponsive and neuroleptic responsive lines of mice: A quantitative receptor autoradiographic study. J Pharmacol Exp Ther 261:341-348.
32. Seeman P, Corbett R, and Van Tol HH (1997) Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacoiogy 16:93-110.
33. Seeman P and Van Tol HHM (1994) Dopamine receptor pharmacology. Trends Pharmacol Sci 15:264-270.
34. Soller M, Brody T and Genizi A (1976) On the power of experimental designs for the direction of linkage between marker loci and quantitative loci in crosses between inbred lines. Theor Appl Genet 47:35-39.
35. A and schizophrenia plus identification of new polymorphisms in the promoter. Mol Psychiatr 3:42-49.
36. Stoof JC, Drukarch B, de Boer P and Weaterlink BH (1992) Regulation of the activity of striatal cholinergic neurons by dopamine. Neuroscience 47:755-770.
37. Swerdlow NR, Hartman PL and Auerbach PP (1995) Changes in sensorimotor inhibition across the menstrual cycle: Implications for neuropsychiatric disorders. Biol Psych 41:452-460.